• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血流感染的流行病学与临床特征:韩国一家教学医院的10年回顾性研究

Epidemiology and Clinical Features of Bloodstream Infections: A 10-Year Retrospective Study in a Korean Teaching Hospital.

作者信息

Yu Shi Nae, Hong Sun In, Park Jung Wan, Jeon Min Hyok, Cho Oh Hyun

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, 31, Suncheonhyang 6-gil, Dongnam-gu, Cheonan 31151, Republic of Korea.

出版信息

J Fungi (Basel). 2025 Mar 12;11(3):217. doi: 10.3390/jof11030217.

DOI:10.3390/jof11030217
PMID:40137255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11942763/
Abstract

species are major pathogens of bloodstream infections (BSIs) in hospitalized patients, with high mortality. This study examined species distribution, clinical characteristics, and the mortality of patients with BSIs. Adult patients (≥16 years) with BSIs at a teaching hospital (2014-2023) were retrospectively reviewed. Over 10 years, 487 isolates were obtained from 462 patients. was the most frequent (38.2%), followed by (21.1%), (20.5%), and (13.3%). The annual incidence of BSIs remained stable ( = 0.525). However, non- species BSIs increased 1.61-fold compared to (95% CI: 1.19-2.19, = 0.002). Fluconazole-non-susceptible isolates increased after 2021 ( = 0.040). The overall 30-day mortality was 40.6%. In the multivariate analysis, a high Charlson comorbidity index (aHR: 1.20, 95% CI: 1.07-1.35, = 0.001) and high SOFA score (aHR: 1.12, 95% CI: 1.02-1.23, = 0.022) were the strongest predictors of 30-day mortality. Meanwhile, BSIs (aHR: 0.46, 95% CI: 0.22-0.99, = 0.047) and central venous catheter removal at any time (aHR: 0.22, 95% CI: 0.13-0.37, < 0.001) were associated with reduced 30-day mortality. The mortality of patients with BSIs was mainly determined by disease severity, while catheter removal was associated with improved survival.

摘要

某些菌种是住院患者血流感染(BSIs)的主要病原体,死亡率很高。本研究调查了血流感染患者的菌种分布、临床特征及死亡率。对一家教学医院(2014 - 2023年)的成年(≥16岁)血流感染患者进行了回顾性分析。在10多年间,从462例患者中分离出487株菌株。某菌种最为常见(38.2%),其次是另一菌种(21.1%)、又一菌种(20.5%)和再一菌种(13.3%)。血流感染的年发病率保持稳定(P = 0.525)。然而,非该常见菌种的血流感染与该常见菌种相比增加了1.61倍(95%置信区间:1.19 - 2.19,P = 0.002)。2021年后,对氟康唑不敏感的菌株有所增加(P = 0.040)。总体30天死亡率为40.6%。在多因素分析中,高Charlson合并症指数(校正风险比:1.20,95%置信区间:1.07 - 1.35,P = 0.001)和高序贯器官衰竭评估(SOFA)评分(校正风险比:1.12,95%置信区间:1.02 - 1.23,P = 0.022)是30天死亡率的最强预测因素。同时,该特定菌种的血流感染(校正风险比:0.46,95%置信区间:0.22 - 0.99,P = 0.047)以及随时拔除中心静脉导管(校正风险比:0.22,95%置信区间:0.13 - 0.37,P < 0.001)与30天死亡率降低相关。血流感染患者的死亡率主要由疾病严重程度决定,而拔除导管与生存率提高相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/11942763/fdd6f8b0caa0/jof-11-00217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/11942763/82668741abee/jof-11-00217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/11942763/fdd6f8b0caa0/jof-11-00217-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/11942763/82668741abee/jof-11-00217-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0c/11942763/fdd6f8b0caa0/jof-11-00217-g002.jpg

相似文献

1
Epidemiology and Clinical Features of Bloodstream Infections: A 10-Year Retrospective Study in a Korean Teaching Hospital.血流感染的流行病学与临床特征:韩国一家教学医院的10年回顾性研究
J Fungi (Basel). 2025 Mar 12;11(3):217. doi: 10.3390/jof11030217.
2
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.念珠菌属所致血流感染的国际监测:1997年在美国、加拿大和南美洲为哨兵计划收集的分离株的发生频率及抗真菌药敏情况。哨兵计划参与组
J Clin Microbiol. 1998 Jul;36(7):1886-9. doi: 10.1128/JCM.36.7.1886-1889.1998.
3
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
4
A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.一项关于日本某大学医院血流感染念珠菌的纵向研究:菌种分布、药敏性、临床特征和死亡率预测因素。
Eur J Clin Microbiol Infect Dis. 2022 Nov;41(11):1315-1325. doi: 10.1007/s10096-022-04499-0. Epub 2022 Sep 26.
5
Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida/bacterial bloodstream infections: a retrospective study.混合念珠菌/细菌血流感染患者的发病率、临床特征、危险因素和结局:一项回顾性研究。
Ann Clin Microbiol Antimicrob. 2022 Nov 1;21(1):45. doi: 10.1186/s12941-022-00538-y.
6
Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.中东卡塔尔念珠菌血症的流行病学:基质辅助激光解吸电离飞行时间质谱在念珠菌属鉴定、菌种分布、转归及药敏模式方面的应用
Infection. 2014 Apr;42(2):393-404. doi: 10.1007/s15010-013-0570-4. Epub 2013 Dec 19.
7
Invasive Bloodstream Infections in Children: The Antifungal Susceptibility, Clinical Characteristics and Impacts on Outcomes.儿童侵袭性血流感染:抗真菌药敏性、临床特征及对预后的影响
Microorganisms. 2023 Apr 28;11(5):1149. doi: 10.3390/microorganisms11051149.
8
Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.美国念珠菌属引起的医院血流感染:菌种分布、临床特征和抗真菌药敏性。
Int J Antimicrob Agents. 2014 Jan;43(1):78-81. doi: 10.1016/j.ijantimicag.2013.09.005. Epub 2013 Oct 12.
9
Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.台湾北部一家教学医院假丝酵母菌血流感染的抗菌药物敏感性和临床结局。
J Microbiol Immunol Infect. 2015 Oct;48(5):552-8. doi: 10.1016/j.jmii.2014.07.007. Epub 2014 Oct 12.
10
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex.与近平滑念珠菌复合体引起的血流感染结局相关的因素。
BMC Infect Dis. 2016 Aug 9;16:387. doi: 10.1186/s12879-016-1704-y.

引用本文的文献

1
Epidemiology and Characteristics of Invasive Yeast Infections in Patients with Hematologic Diseases: 12-Year Single-Center Retrospective Cohort Study.血液系统疾病患者侵袭性酵母菌感染的流行病学及特征:一项为期12年的单中心回顾性队列研究
J Fungi (Basel). 2025 Aug 8;11(8):585. doi: 10.3390/jof11080585.
2
Multidrug-Resistant Candida in Bloodstream Infections: A Growing Concern in Indian Healthcare.血流感染中的多重耐药念珠菌:印度医疗保健领域日益关注的问题。
Cureus. 2025 Jun 5;17(6):e85420. doi: 10.7759/cureus.85420. eCollection 2025 Jun.
3
Epidemiological characteristics, antifungal susceptibility, and mortality factors of candidemia in adults at a tertiary teaching hospital in Zunyi, China (2016-2023).

本文引用的文献

1
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study.念珠菌血症的归因死亡率——欧洲临床微生物与感染性疾病学会念珠菌III期多国欧洲观察性队列研究结果
J Infect. 2024 Sep;89(3):106229. doi: 10.1016/j.jinf.2024.106229. Epub 2024 Jul 16.
2
rates in blood culture on the rise: results of US surveillance.血培养阳性率呈上升趋势:美国监测结果
Microbiol Spectr. 2023 Aug 25;11(5):e0221623. doi: 10.1128/spectrum.02216-23.
3
European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study.
中国遵义某三级教学医院成人念珠菌血症的流行病学特征、抗真菌药敏性及死亡因素(2016 - 2023年)
BMC Infect Dis. 2025 May 21;25(1):726. doi: 10.1186/s12879-025-11021-2.
欧洲念珠菌血症具有显著的不同流行病学特征和药敏模式:欧洲临床微生物与感染性疾病学会念珠菌III期研究结果
J Infect. 2023 Nov;87(5):428-437. doi: 10.1016/j.jinf.2023.08.001. Epub 2023 Aug 6.
4
Invasive candidiasis: current clinical challenges and unmet needs in adult populations.侵袭性念珠菌病:成人患者的当前临床挑战和未满足的需求。
J Antimicrob Chemother. 2023 Jul 5;78(7):1569-1585. doi: 10.1093/jac/dkad139.
5
Nationwide Surveillance of Antifungal Resistance of Bloodstream Isolates in South Korean Hospitals: Two Year Report from Kor-GLASS.韩国医院血流分离株抗真菌耐药性的全国性监测:来自Kor-GLASS的两年报告
J Fungi (Basel). 2022 Sep 22;8(10):996. doi: 10.3390/jof8100996.
6
A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors.一项关于日本某大学医院血流感染念珠菌的纵向研究:菌种分布、药敏性、临床特征和死亡率预测因素。
Eur J Clin Microbiol Infect Dis. 2022 Nov;41(11):1315-1325. doi: 10.1007/s10096-022-04499-0. Epub 2022 Sep 26.
7
Mortality-associated factors of candidemia: a multi-center prospective cohort in Turkey.**菌血症相关死亡因素**:土耳其多中心前瞻性队列研究
Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):597-607. doi: 10.1007/s10096-021-04394-0. Epub 2022 Jan 27.
8
Epidemiology, species distribution, and outcome of nosocomial Candida spp. bloodstream infection in Shanghai: an 11-year retrospective analysis in a tertiary care hospital.上海某三级医院医院获得性念珠菌血流感染的流行病学、菌种分布及转归:一项 11 年回顾性分析。
Ann Clin Microbiol Antimicrob. 2021 May 13;20(1):34. doi: 10.1186/s12941-021-00441-y.
9
Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008-2018.氟康唑耐药光滑念珠菌血流感染分离株,韩国,2008-2018 年。
Emerg Infect Dis. 2021 Mar;27(3):779-788. doi: 10.3201/eid2703.203482.
10
Trends in the Epidemiology of Candidemia in Intensive Care Units From 2006 to 2017: Results From the Korean National Healthcare-Associated Infections Surveillance System.2006年至2017年重症监护病房念珠菌血症的流行病学趋势:韩国国家医疗保健相关感染监测系统的结果
Front Med (Lausanne). 2020 Dec 17;7:606976. doi: 10.3389/fmed.2020.606976. eCollection 2020.